Synapse Lung Nodule AI— 510(k) K254075

Substantially Equivalent

Fujifilm Corporation

FDA 510(k) clearance K254075 for Synapse Lung Nodule AI, Substantially Equivalent on 2026-05-27. Applicant: Fujifilm Corporation. Device class: 2.

Summary

Fujifilm's Synapse Lung Nodule AI is filed under OEB, computer-aided detection for lung computed tomography systems.

Class II, 21 CFR 892.2050. Radiology is both the classification panel and the review panel, and the submission was a Traditional 510(k).

Fujifilm filed from Minato-Ku, Tokyo, Japan. Review took 160 calendar days (December 18, 2025 to May 27, 2026).

Clearance details

Applicant
Fujifilm Corporation
Product code
Product code OEB
Device class
Class 2
Regulation
21 CFR 892.2050
Advisory panel
Radiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Minato-Ku, Tokyo, JP
Download summary PDFView on FDA.gov ↗

Recent devices under product code OEB

view all

More clearances from Fujifilm Corporation

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.